Skip to main content
. 2021 Jul 17;1:100013. doi: 10.1016/j.lana.2021.100013

Table 3.

Weighted number and prevalence of CKD patients within subgroups of survey participants

Subgroup Unweighted No. of CKD patients Weighted No. of CKD patients (95% CI) Weighted prevalence of CKD (95% CI) P value
All CKD patients 1,141 20,924 ( 19,275 - 22,573 )
Age ≥ 40 years <0·001 *
 Yes 653 10,223 ( 9,266 - 11,180 ) 20·7 ( 19·0 - 22·4 )
 No 488 10,701 ( 9,251 - 12,153 ) 10·4 ( 9·1 - 11·7 )
Sex 0·005 *
 Women 725 12,043 ( 10,817 - 13,269 ) 14·8 ( 13·5 - 16·2 )
 Men 416 8,881 ( 7,836 - 9,928 ) 12·5 ( 11·1 - 13·8 )
Ethnicity <0·001 *
 Maya 101 1,371 ( 934 - 1,810 ) 8·4 ( 6·2 - 10·6 )
 Black 190 5,014 ( 4,042 - 5,986 ) 11·7 ( 9·7 - 13·8 )
 Mestizo/Hispanic 736 12,877 ( 11,440 - 14,314 ) 15·2 ( 13·8 - 16·7 )
 Others 114 1,662 ( 1,070 - 2,254 ) 18·2 ( 14·1 - 22·3 )
Literacy 0·036 *
 Literate 876 16,585 ( 14,938 - 18,232 ) 13·3 ( 12·1 - 14·5 )
 Illiterate 265 4,339 ( 3,656 - 5,024 ) 15·5 ( 13·5 - 17·6 )
Employment 0·939
 Employed 709 13,975 ( 12,488 - 15,462 ) 13·7 ( 12·4 - 15·0 )
 Unemployed 432 6,949 ( 6,092 - 7,806 ) 13·8 ( 12·3 - 15·3 )
District <0·001 *
 Corozal 223 3,199 ( 2,546 - 3,852 ) 16·6 ( 13·5 - 19·6 )
 Orange Walk 311 3,796 ( 3,270 - 4,322 ) 18·8 ( 16·2 - 21·4 )
 Belize 185 6,237 ( 5,076 - 7,398 ) 13·0 ( 10·7 - 15·2 )
 Cayo 224 5,038 ( 3,922 - 6,154 ) 14·0 ( 11·5 - 16·5 )
 Stann Creek 97 1,556 ( 1,098 - 2,014 ) 9·5 ( 6·8 - 12·2 )
 Toledo 101 1,098 ( 790 - 1,406 ) 8·6 ( 6·4 - 10·9 )
Residence area 0·976
 Rural 735 11,168 ( 9,797 - 12,539 ) 13·7 ( 12·2 - 15·2 )
 Urban 406 9,756 ( 8,445 - 11,067 ) 13·7 ( 12·0 - 15·4 )
Diabetes <0·001 *
 Yes 168 2,754 ( 2,320 - 3,188 ) 28·1 ( 23·8 - 32·3 )
 No 973 18,170 ( 16,406 - 19,934 ) 12·7 ( 11·6 - 13·9 )
Hypertension <0·001 *
 Yes 544 9,527 ( 8,442 - 10,612 ) 18·5 ( 16·7 - 20·3 )
 No 597 11,397 ( 10,082 - 12,714 ) 11·3 ( 10·0 - 12·5 )
Hypercholesterolaemia <0·001 *
 Yes 601 10,804 ( 9,548 - 12,060 ) 17·3 ( 15·6 - 19·0 )
 No 540 10,120 ( 8,972 - 11,268 ) 11·2 ( 10·0 - 12·4 )
Obesity <0·001 *
 Yes 601 10,238 ( 9,152 - 11,324 ) 16·4 ( 14·8 - 18·0 )
 No 540 10,686 ( 9,400 - 11,972 ) 11·8 ( 10·6 - 13·1 )
Gout 0·003 *
 Yes 45 639 ( 456 - 821 ) 21·6 ( 15·6 - 27·6 )
 No 1,096 20,285 ( 18,421 - 22,151 ) 13·6 ( 12·4 - 14·7 )
Ever smoked
 Yes 298 6,246 ( 5,334 - 7,158 ) 13·3 ( 11·5 - 15·1 ) 0·520
 No 843 14,678 ( 13,193 - 16,163 ) 13·9 ( 12·7 - 15·2 )
Frequent alcohol consumption
 Yes 130 3,170 ( 2,458 - 3,882 ) 12·9 ( 10·3 - 15·6 ) 0·515
 No 1,011 17,754 ( 16,099 - 19,409 ) 13·9 ( 12·7 - 15·0 )
Ever used NSAIDs
 Yes 522 9,483 ( 8,411 - 10,555 ) 13·2 ( 11·9 - 14·6 ) 0·278
 No 619 11,441 ( 10,153 - 12,731 ) 14·1 ( 12·7 - 15·6 )
Ever used herbal medicines
 Yes 567 10,626 ( 9,459 - 11,793 ) 13·9 ( 12·5 - 15·3 ) 0·713
 No 574 10,298 ( 9,106 - 11,492 ) 13·6 ( 12·1 - 15·0 )
Exercised ≥ 90 min per week
 Yes 182 3,820 ( 3,114 - 4,526 ) 13·1 ( 10·9 - 15·2 ) 0·498
 No 959 17,104 ( 15,461 - 18,747 ) 13·9 ( 12·7 - 15·1 )

Note. Variables are weighted using the sampling weights accounting for the population structure in the 2010 census and the estimated size of Belize's population in 2017. CI, confidence interval; CKD, chronic kidney disease; NSAID, nonsteroidal anti-inflammatory drug.

P value ≤ 0·05.